Skip to main content
Clinical Trials/CTRI/2019/05/019203
CTRI/2019/05/019203
Active, not recruiting
Phase 2

Modalities of therapeutic intervention and assessment of multisystem complications in idiopathic hypoparathyroidism

All India Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E200- Idiopathic hypoparathyroidism
Sponsor
All India Institute of Medical Sciences
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • All the patients with idiopathic hypoparathyroidism who are willing to participate and come for regular follow up for at least three months from the date of achieving ideal control serum calcium level between 8\.0\-9\.5 mg/dl

Exclusion Criteria

  • Suboptimal calcium control with serum calcium less than 8\.0 mg/dl,
  • History of poor compliance with follow up and or drugs in the previous trials
  • Not willing to visit at the designated interval of every 15 days during adjustment of therapy
  • history of any other active illness or hypocalcemic seizures during last six months

Outcomes

Primary Outcomes

Not specified

Similar Trials